Skip to content

NC Emerge® H7493926815400Recalls & reported problems

Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2

All models of NC Emerge (61)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729858263), received between Nov 29, 2021 and Nov 29, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult to Remove” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 29, 2021Difficult to Remove; Difficult to Remove

    IT WAS REPORTED THAT THE BALLOON WAS DIFFICULT TO REMOVE FROM STENT. THE TARGET LESION WAS LOCATED IN THE LEFT MAIN ARTERY. A 4.00MM X 15MM NC EMERGE BALLOON CATHETER WAS ADVANCED FOR POST-DILATATION. HOWEVER, DURING THE PROCEDURE, THE BALLOON GOT STUCK IN THE STENT STRUTS. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12882157 ↗

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page